(Q54053126)

24 May 2018

title

Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor. (English)

1 reference

24 May 2018

author name string

Fass R

1

1 reference

24 May 2018

Sampliner RE

2

1 reference

24 May 2018

Malagon IB

3

1 reference

24 May 2018

Hayden CW

4

1 reference

24 May 2018

Camargo L

5

1 reference

24 May 2018

Wendel CS

6

1 reference

24 May 2018

Garewal HS

7

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 May 2000

1 reference

24 May 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

24 May 2018

volume

14

1 reference

24 May 2018

issue

5

1 reference

24 May 2018

page(s)

597-602

1 reference

24 May 2018

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

Regression of Barrett's esophagus by laser ablation in an anacid environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

Laser-induced transient regression of Barrett's epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

Ablative therapies for the columnar-lined esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00749.X

10.1046/J.1365-2036.2000.00749.X

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018